Interstitial lung disease in India keep searching and you'll keep finding

American Journal of Respiratory and Critical Care Medicine

Volumn 195, Issue 6, 2017, Pages 714-715

  Udwadia, Zarir F ^a   Richeldi, Luca ^b,c  

^a BREACH CANDY HOSPITAL   (India)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC PNEUMONITIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DISEASE REGISTRY; EDITORIAL; FIBROSING ALVEOLITIS; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HUMAN; INDIA; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; PUBLIC HEALTH; SARCOIDOSIS; TUBERCULOSIS;

HUMANS; INDIA; LUNG DISEASES, INTERSTITIAL;

EID: 85015962412     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201610-2019ED     Document Type: Editorial

References (12)

1. Singh S, Collins BF, Sharma BB, Joshi JM, Talwar D, Katiyar S, Singh N, Ho L, Samaria JK, Bhattacharya P, et al. Interstitial lung disease in India: Results of a prospective registry. Am J Respir Crit Care Med 2017;195:801-813.
2. Jindal SK, Malik SK, Deodhar SD, Sharma BK. Fibrosing alveolitis: A report of 61 cases seen over the past five years. Indian J Chest Dis Allied Sci 1979;21:174-179.
3. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al.; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-748.
4. Global Tuberculosis Control. Global tuberculosis report 2016. Geneva: World Health Organization; 2015 [accessed 2016 Nov 1]. Available from: Http://www.who.int/tb/publications/global-report/en/
5. Poey C, Verhaegen F, Giron J, Lavayssiere J, Fajadet P, Duparc B. High resolution chest CT in tuberculosis: Evolutive patterns and signs of activity. J Comput Assist Tomogr 1997;21:601-607.
6. Udwadia ZF, Sen T, Jindal SK. Interstitial lung disease in a resource limited setting: The case of India. In: Du Bois RM, Richeldi L, editors. Interstitial lung diseases. European Respiratory Society Monographs; 2009.
7. Sen T, Udwadia ZF. Retrospective study of interstitial lung disease in a tertiary care centre in India. Indian J Chest Dis Allied Sci 2010;52:207-211.
8. Schuyler M, Cormier Y. The diagnosis of hypersensitivity pneumonitis. Chest 1997;111:534-536.
9. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F, Erkinjuntti-Pekkanen R, Muller N, Colby TV, Schuyler M, et al.; HP Study Group. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003;168:952-958.
10. World Health Organization. Country cooperation strategy. India 2012-2017. Geneva: World Health Organization [accessed 2016 Nov 1]. Available from: Http://www.who.int/countryfocus
11. Economy: India and United States compared. Woolwich: NationMaster [accessed 2016 Nov 1]. Available from: Http://www.nationmaster. com/country-info/compare/India/United-States/Economy
12. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al.; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-2082.